Insider buying
~$64K20K sh @ $3.19
Traded May 14, 2025 · filed 5 days later
A Protara Therapeutics director paid $64K out of pocket for Protara Therapeutics shares. Shares held went up 65% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 14, 2025 · Filed May 16, 2025
A Protara Therapeutics director paid $64K out of pocket for Protara Therapeutics shares. Shares held went up 65% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$63,800
Shares × reported transaction price
$25K–$100K
+64.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
6 days after results of May 8, 2025, 89 days before results of Aug 11, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded May 14, 2025 · filed 5 days later
A Protara Therapeutics director paid $64K out of pocket for Protara Therapeutics shares. Shares held went up 65% with this purchase.
Jacqueline Zummo (Chf Scientific Operations Off) sold ~$96K of Protara Therapeutics
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.